These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 34579027)

  • 1. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
    Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
    Front Immunol; 2022; 13():829525. PubMed ID: 35185922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
    Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
    Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.
    Banfi D; Moro E; Bosi A; Bistoletti M; Cerantola S; Crema F; Maggi F; Giron MC; Giaroni C; Baj A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Li N; Zhan S; Tian Z; Liu C; Xie Z; Zhang S; Chen M; Zeng Z; Zhuang X
    Inflamm Bowel Dis; 2021 Aug; 27(9):1525-1540. PubMed ID: 33399195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic analysis of bile salt biotransformation in the human gut microbiome.
    Das P; Marcišauskas S; Ji B; Nielsen J
    BMC Genomics; 2019 Jun; 20(1):517. PubMed ID: 31234773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.
    Di Ciaula A; Bonfrate L; Khalil M; Portincasa P
    Intern Emerg Med; 2023 Nov; 18(8):2181-2197. PubMed ID: 37515676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.
    Han B; Lv X; Liu G; Li S; Fan J; Chen L; Huang Z; Lin G; Xu X; Huang Z; Zhan L; Lv X
    Gut Microbes; 2023; 15(1):2232143. PubMed ID: 37431863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
    Lavelle A; Sokol H
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversification of host bile acids by members of the gut microbiota.
    Winston JA; Theriot CM
    Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.